Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Sulfadiazine, Trimethoprim
Norbrook Laboratories Limited
QJ01EW10
Sulfadiazine, Trimethoprim
Tablet
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Antimicrobial
Expired
1998-01-21
Revised 14 October 2008 AN: 00051/2008 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Trimacare 80 Tablets for Dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Each tablet contains: Trimethoprim 80 mg Sulfadiazine 400 mg. EXCIPIENTS: For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet White circular uncoated tablets scored on one side. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES When susceptible organisms are present the combination may be effective in treating the following conditions: alimentary tract infections, respiratory and urogenital infections, skin and wound infections and eye and ear infections. 4.3 CONTRA-INDICATIONS Not suitable for use in cats. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No special warnings. Revised 14 October 2008 AN: 00051/2008 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Wherever possible, use of Trimacare should be based on suceptability testing. Not to be used in cases of hepatic or renal impairment, or blood dyscrasia. Maintain adequate fluid intake during treatment. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Take care to avoid skin contact. Wash hands after use. Sulphonamides may cause hypersensitivty (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to sulphonamides may lead to cross reactions with other antibiotics. Allergic reactions to these subatances may occasionally be serious. 1. Do not handle this product if you know you are sensitive to sulphonamides. 2. If you develop symptoms following exposure such as a skin rash, you should seek medical advice and show the doctor this warning. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) A low incidence of polyarthropathy and Keratoconjunctivitis Sicca (Dry Eye) has been reported in dogs following oral administration of potentiated sulphonamides. If either of these cond Read the complete document